✦ LIBER ✦
6010 A three-arm phase III randomized trial of FOLFOX-4 vs. FOLFOX-4 plus bevacizumab vs. XELOX plus bevacizumab in the adjuvant treatment of patients with stage III or high-risk stage II colon cancer: results of the interim safety analysis of the AVANT trial
✍ Scribed by Hoff, P.; Clarke, S.; Cunningham, D.; Van Cutsem, E.; Moore, M.; Schmoll, H.J.; Tabernero, J.; Mueller, B.; De Gramont, A.
- Book ID
- 123017328
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 48 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.